Randy H. Thurman
CIK: 0001204059
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Outlook Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 26, 2026OTLK
Outlook Therapeutics, Inc.
Purchase(P)Direct5K shares at avg. $0.43$2K - Oct 1, 2025OTLK
Outlook Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
286.7K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
56.6K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
89.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 | OTLK Outlook Therapeutics, Inc. | Purchase(P) | 5,000 | $0.43 | $2,145 | Direct |
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 286,734 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 56,636 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 89,549 | - | - | Direct |
1-4 of 4 transactions
About THURMAN RANDY H
THURMAN RANDY H (SEC CIK 0001204059) files insider reports with the SEC as Director of Outlook Therapeutics, Inc. (OTLK).
Signal8 holds 3 ownership filings by THURMAN RANDY H, all Form 4s, filed between Oct 3, 2024 and May 27, 2026. Those filings report 4 transactions, from Oct 1, 2024 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on THURMAN RANDY H's filings is in ISELIN, NJ.
Recent filings by THURMAN RANDY H
Other insiders filing for Outlook Therapeutics, Inc. (OTLK)
- Lundquist Kevin Michael, Chief Financial Officer
- Jahr Robert Charles, Chief Executive Officer
- Sukhtian Ghiath M., Director
- KENYON LAWRENCE A, Chief Financial Officer
- Sukhtian Faisal Ghiath, Director
- Haddadin Yezan Munther, Director